Patents by Inventor Yuming Xu

Yuming Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10439752
    Abstract: Optical switch control circuit for optical network protection. In an exemplary embodiment, an apparatus includes a latching optical switch that routes signals in an optical network. The apparatus also includes a switch control circuit coupled to the latching optical switch. The switch control circuit controls the latching optical switch to selectively operate in a latching mode or in a non-latching mode based on a received command and a network power state. A method is disclosed that includes receiving a command that indicates how optical signals are to be routed by a latching optical switch, and determining a resulting routing state based on a current routing state, the command, and a power state. The method also includes controlling the latching optical switch to operates in the resulting routing state such that the latching optical switch selectively operates in a latching mode or in a non-latching mode.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: October 8, 2019
    Assignee: OptiWorks (Kunshan) Co., Ltd.
    Inventors: Sichao Wang, Chenlei Shao, Sheng Zhou, Yuming Xu, Chen Zhang, Chuanxing Zhu, Yanyan Ma
  • Publication number: 20190229832
    Abstract: Optical switch control circuit for optical network protection. In an exemplary embodiment, an apparatus includes a latching optical switch that routes signals in an optical network. The apparatus also includes a switch control circuit coupled to the latching optical switch. The switch control circuit controls the latching optical switch to selectively operate in a latching mode or in a non-latching mode based on a received command and a network power state. A method is disclosed that includes receiving a command that indicates how optical signals are to be routed by a latching optical switch, and determining a resulting routing state based on a current routing state, the command, and a power state. The method also includes controlling the latching optical switch to operates in the resulting routing state such that the latching optical switch selectively operates in a latching mode or in a non-latching mode.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 25, 2019
    Inventors: Sichao Wang, Chenlei Shao, Sheng Zhou, Yuming Xu, Chen Zhang, Chuanxing Zhu, Yanyan Ma
  • Publication number: 20180298375
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, arid antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: March 9, 2018
    Publication date: October 18, 2018
    Applicant: INCYTE CORPORATION
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Walia, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Kaulback, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J.A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangavelu, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao M. Tran, Craig H. Ison, Brendan M. Duggan, Stephanie Sapperstein Kareht
  • Patent number: 9914921
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: March 13, 2018
    Assignee: INCYTE CORPORATION
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Walia, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Kaulback, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J. A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangaveln, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao M. Tran, Craig H. Ison, Brendan M. Duggan, Stephanie Kareht
  • Publication number: 20170166888
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: December 23, 2016
    Publication date: June 15, 2017
    Applicant: INCYTE CORPORATION
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Walia, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Kaulback, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J.A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangaveln, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao M. Tran, Craig H. Ison, Brendan M. Duggan, Stephanie Kareht
  • Patent number: 9567383
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: February 14, 2017
    Assignee: INCYTE CORPORATION
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Walia, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Kaulback, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J. A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangaveln, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao M. Tran, Craig H. Ison, Brendan M. Duggan, Stephanie Kareht
  • Publication number: 20150004165
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: September 8, 2014
    Publication date: January 1, 2015
    Applicant: INCYTE CORPORATION
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Walia, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Kaulback, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J.A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangaveln, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao M. Tran, Craig H. Ison, Brendan M. Duggan, Stephanie Kareht
  • Patent number: 8889833
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: November 18, 2014
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Walia, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Elliott Kaulback, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J. A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangaveln, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao M. Tran, Craig H. Ison, Brendan M. Duggan, Stephanie Kareht
  • Publication number: 20140056906
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: October 8, 2013
    Publication date: February 27, 2014
    Applicant: INCYTE CORPORATION
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Walia, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Elliott, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J. A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangaveln, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao Tran, Craig H. Ison, Brendan M. Duggan, Stephanie Sapperstein
  • Patent number: 8569445
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Grant
    Filed: September 14, 2009
    Date of Patent: October 29, 2013
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Chawla, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Elliott, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J. A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangavelu, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao Tran, Craig H. Ison, Brendan M. Duggan, Stephanie K. Sapperstein
  • Publication number: 20100099617
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: September 14, 2009
    Publication date: April 22, 2010
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder K. Chawla, Madhusudan M. Sanjanwala, Michael B. Thornton, Vicki S. Elliott, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J. A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangavelu, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao Tran, Craig H. Ison, Brendan M. Duggan, Stephanie K. Sapperstein
  • Patent number: 7608704
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: October 27, 2009
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Monique G. Yao, Ameena R. Gandhi, Mariah R. Baughn, Anita Swarnakar, Narinder Chawla, Madhusudan M. Sanjanwala, Michael Thorton, Vicki S. Elliott, Yan Lu, Kimberly J. Gietzen, Neil Burford, Li Ding, April J. A. Hafalia, Y. Tom Tang, Olga Bandman, Bridget A. Warren, Cynthia D. Honchell, Dyung Aina M. Lu, Kavitha Thangavelu, Sally Lee, Yuming Xu, Junming Yang, Preeti G. Lal, Bao Tran, Craig H. Ison, Brendan M. Duggan, Stephanie K. Sapperstein
  • Publication number: 20070092885
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: March 20, 2006
    Publication date: April 26, 2007
    Inventors: Henry Yue, Monique Yao, Ameena Gandhi, Mariah Baughn, Anita Swarnakar, Narinder Chawla, Madhusudan Sanjanwala, Michael Thornton, Vicki Elliott, Yan Lu, Kimberly Gietzen, Neil Burford, Li Ding, April Hafalia, Y. Tang, Olga Bandman, Bridget Warren, Cynthia Honchell, Dyung Lu, Kavitha Thangavelu, Sally Lee, Yuming Xu, Junming Yang, Preeti Lal, Bao Tran, Craig Ison, Brendan Duggan, Stephanie Sapperstein
  • Publication number: 20060196812
    Abstract: A method includes diluting a bitumen source, such a bitumen froth from a hot water extraction process, with a hydrocarbon diluent such as naphtha, contacting the bitumen with a zone settling aid such as a polyoxyalkylate block polymer, flocculating water and fine solids in the diluted bitumen, separating the flocculated water and fine solids from the solvent-diluted bitumen, and producing dry, clean diluted bitumen. Preferably, the diluted bitumen will have less than 1.0 wt % water, but most preferably less than 0.7 wt % water. The method may further comprise maintaining the diluted bitumen under conditions that avoid the precipitation of asphaltenes from the bitumen, preferably such that the dry, clean diluted bitumen comprises essentially all, such as greater than 96%, of the asphaltene content from the bitumen source. Counter-current flow may be performed in a series of zone settling stages, such as with gravity settling.
    Type: Application
    Filed: March 2, 2006
    Publication date: September 7, 2006
    Inventors: Jan Beetge, Petrus Johannes Venter, Wang Sanyi, Xiaoli Yang, Yicheng Long, Yuming Xu, Tadeusz Dabros, Hassan Hamza
  • Publication number: 20060194275
    Abstract: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.
    Type: Application
    Filed: April 12, 2002
    Publication date: August 31, 2006
    Applicant: INCYTE CORPORATION
    Inventors: Mariah Baughn, Vicki Elliott, April Hafalia, Junming Yang, Narinder Chawla, Jayalaxmi Ramkumar, Ian Forsythe, Yan Lu, Y Tom Tang, Henry Yue, Brigitte Raumann, Preeti Lal, Yalda Azimzai, Dyung Lu, Ameena Gandhi, Michael Thornton, Danniel Nguyen, Chandra Arvizu, Brooke Emerling, Anita Swarnakar, Monique Yao, Li Ding, Ann He, Jennifer Griffin, Madhusudan Sanjanwala, Kimberly Gietzen, Ernestine Lee, Yuming Xu, Janice Au-Young, Debopriya Das, Soo Lee, Hsin-Ru Chang
  • Publication number: 20060127894
    Abstract: Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.
    Type: Application
    Filed: August 8, 2002
    Publication date: June 15, 2006
    Applicant: Incyte Corporation
    Inventors: Yalda Azimzai, Ines Barroso, Mariah Baughn, Shanya Becha, Mark Borowsky, Brendan Duggan, Vicki Elliott, Brooke Emerling, Ian Forsythe, Kimberly Gietzen, Ann Gorvad, Richard Graul, Jennifer Griffin, Rajagopal Gururajan, April Hafalia, Craig Ison, Amy Kable, Farrah Khan, Sally Lee, Soo Lee, Joana Li, Roopa Reddy, Thomas Richardson, William Sprague, Anita Swarnakar, Y. Tom Tang, Bridget Warren, Yuming Xu, Monique Yao, Henry Yue, Huibin Yue
  • Patent number: 7029897
    Abstract: The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: April 18, 2006
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Li Ding, Preeti G. Lal, Jennifer A. Griffin, Rajagopal Gururajan, Mariah R. Baughn, Craig H. Ison, Jayalaxmi Ramkumar, Catherine M. Tribouley, Anita Swarnakar, Neil Burford, Olga Bandman, Michael Thornton, Farrah A. Khan, Narinder K. Chawla, Danniel B. Nguyen, Vicki S. Elliott, Yuming Xu, Yan Lu, April J. A. Hafalia, Monique G. Yao, Ameena R. Gandhi, Chandra S. Arvizu, Ian J. Forsythe
  • Publication number: 20050176927
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: December 12, 2001
    Publication date: August 11, 2005
    Inventors: Jennifer Griffin, Monique Yao, Brendan Duggan, Henry Yue, Li Ding, Preeti Lal, Ernestine Lee, Jayalaxmi Ramkumar, Kavitha Thangavelu, Yuming Xu, Sally Lee, Y. Tang, Danniel Nguyen, Bridget Warren, Cynthia Honchell, Kimberly Gietzen, Mariah Baughn, Ameena Gandhi, Chandra Arvizu, Narinder Chawla, Yan Lu, Vicki Elliott, Dyung Lu, April J A Hafalia, Yalda Azimzai, Farrah Khan, Uyen Tran
  • Publication number: 20050176944
    Abstract: Various embodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.
    Type: Application
    Filed: August 16, 2002
    Publication date: August 11, 2005
    Inventors: Henry Yue, Dyung Lu, Anita Swarnakar, Y. Tang, Jennifer Griffin, Brooke Emerling, Ian Forsythe, Monique Yao, Jayalaxmi Ramkumar, Thomas Richardson, Shanya Becha, Ernestine Lee, Bridget Warren, Patricia Lehr-Mason, Mariah Baughn, Joana Li, Brendan Duggan, Kimberly Gietzen, Preeti Lal, Mark Borowsky, Craig Ison, Kavitha Thangavelu, Yuming Xu, Sally Lee, Vicki Elliott, William Sprague, Yalda Azimzai, April Hafalia, Li Ding, Danniel Nguyen, Cynthia Honchell, Wen Luo, Narinder Chawla, Joseph Marquis, Jennifer Jackson, Uyen Tran
  • Publication number: 20050142600
    Abstract: The invention provides human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.
    Type: Application
    Filed: February 1, 2005
    Publication date: June 30, 2005
    Inventors: Bridget Warren, Cynthia Honchell, Yan Lu, Narinder Chawla, Neil Burford, Angelo Delegeane, Ameena Gandhi, Mariah Baughn, Jennifer Griffin, Kimberly Gietzen, Dyung Lu, Craig Ison, Jayalaxmi Ramkumar, Y. Tang, Preeti Lal, Mark Borowsky, Brendan Duggan, April Hafalia, Chandra Arvizu, Kavitha Thangavelu, Monique Yao, Vicki Elliott, Li Ding, Henry Yue, Sally Lee, Anita Swarnakar, Uyen Tran, Yuming Xu